Treatment of cognitive dysfunction in adults with major depressive disorder

[1]  D. Lawlor,et al.  Exercise for Depression. , 1978, The Physician and sportsmedicine.

[2]  S. Kennedy,et al.  The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: Results from a randomized controlled trial , 2014, Psychiatry Research.

[3]  R. DeRubeis,et al.  Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. , 2014, JAMA psychiatry.

[4]  Karen S. Abraham,et al.  Neurocognitive predictors of antidepressant clinical response. , 2014, Journal of affective disorders.

[5]  A. Thorsen,et al.  Neurobiology of Cognitive Remediation Therapy for Schizophrenia: A Systematic Review , 2014, Front. Psychiatry.

[6]  F. Legrand.  Effects of exercise on physical self-concept, global self-esteem, and depression in women of low socioeconomic status with elevated depressive symptoms. , 2014, Journal of sport & exercise psychology.

[7]  M. Trivedi,et al.  Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder , 2014, Neuropsychopharmacology.

[8]  R. McIntyre,et al.  A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults , 2014, The international journal of neuropsychopharmacology.

[9]  M. Vinberg,et al.  Psychostimulants in moderate to severe affective disorder: A systematic review of randomized controlled trials , 2013, Nordic journal of psychiatry.

[10]  G. Faulkner,et al.  Physical activity and the prevention of depression: a systematic review of prospective studies. , 2013, American journal of preventive medicine.

[11]  B. Sahakian,et al.  Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials. , 2013, The Journal of clinical psychiatry.

[12]  C. Bowie,et al.  Cognitive Remediation for Treatment-Resistant Depression: Effects on Cognition and Functioning and the Role of Online Homework , 2013, The Journal of nervous and mental disease.

[13]  D. Denys,et al.  Cognitive Functioning in Psychiatric Disorders Following Deep Brain Stimulation , 2013, Brain Stimulation.

[14]  Paul Kudlow,et al.  COGNITIVE DEFICITS AND FUNCTIONAL OUTCOMES IN MAJOR DEPRESSIVE DISORDER: DETERMINANTS, SUBSTRATES, AND TREATMENT INTERVENTIONS , 2013, Depression and anxiety.

[15]  J. Ramaekers,et al.  A Randomized Trial on the Acute and Steady‐State Effects of a New Antidepressant, Vortioxetine (Lu AA21004), on Actual Driving and Cognition , 2013, Clinical pharmacology and therapeutics.

[16]  Zhi-qiang Zhuang,et al.  Cardiac Peroxisome Proliferator-Activated Receptor-γ Expression is Modulated by Oxidative Stress in Acutely Infrasound-Exposed Cardiomyocytes , 2013, Cardiovascular Toxicology.

[17]  Kazutoshi Ebe,et al.  Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers , 2013, Human psychopharmacology.

[18]  Á. Pascual-Leone,et al.  Can noninvasive brain stimulation enhance cognition in neuropsychiatric disorders? , 2013, Neuropharmacology.

[19]  H. Schiöth,et al.  Intranasal Treatment of Central Nervous System Dysfunction in Humans , 2012, Pharmaceutical Research.

[20]  S. Kennedy,et al.  A randomized, double‐blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder , 2012, Bipolar disorders.

[21]  M. Trivedi,et al.  Does exercise improve self-reported sleep quality in non-remitted major depressive disorder? , 2012, Psychological Medicine.

[22]  M. Trivedi,et al.  Pro-Inflammatory Cytokines as Predictors of Antidepressant Effects of Exercise in Major Depressive Disorder , 2012, Molecular Psychiatry.

[23]  Cornelius Katona,et al.  A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder , 2012, International clinical psychopharmacology.

[24]  F. Hjärthag,et al.  Psychometric properties of a performance-based measurement of functional capacity, the UCSD Performance-based Skills Assessment - Brief version , 2012, Psychiatry Research.

[25]  Steven S. Henley,et al.  Exercise as an augmentation treatment for nonremitted major depressive disorder: a randomized, parallel dose comparison. , 2011, The Journal of clinical psychiatry.

[26]  D. McLoughlin,et al.  Objective Cognitive Performance Associated with Electroconvulsive Therapy for Depression: A Systematic Review and Meta-Analysis , 2010, Biological Psychiatry.

[27]  E. Gudayol-Ferré,et al.  Major Depressive Disorder in recovery and neuropsychological functioning: effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery. , 2010, Journal of affective disorders.

[28]  E. Gudayol-Ferré,et al.  Effects of selective serotonin reuptake and dual serotonergic–noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder , 2010, Psychiatry Research.

[29]  S. Kennedy,et al.  Attention-deficit/hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the international mood disorders collaborative project. , 2010, Primary care companion to the Journal of clinical psychiatry.

[30]  I. Hickie,et al.  Cognitive training in affective disorders improves memory: a preliminary study using the NEAR approach. , 2010, Journal of affective disorders.

[31]  W. Hulstijn,et al.  Psychomotor Changes in Major Depressive Disorder during Sertraline Treatment , 2009, Neuropsychobiology.

[32]  J. Rybakowski,et al.  Enhancing effect of mirtazapine on cognitive functions associated with prefrontal cortex in patients with recurrent depression. , 2007, Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology.

[33]  G. MacQueen,et al.  Successful computer-assisted cognitive remediation therapy in patients with unipolar depression: a proof of principle study , 2007, Psychological Medicine.

[34]  R. Mohs,et al.  Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. , 2007, The American journal of psychiatry.

[35]  P. Falkai,et al.  Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression , 2005, British Journal of Psychiatry.

[36]  K. Wesnes,et al.  Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients , 2003, International clinical psychopharmacology.

[37]  M. Posternak,et al.  How should remission from depression be defined? The depressed patient's perspective. , 2006, The American journal of psychiatry.

[38]  B. Gillain,et al.  Effects of sertraline on depressive symptoms and attentional and executive functions in major depression , 2005, Depression and anxiety.

[39]  T L Patterson,et al.  UCSD Performance-Based Skills Assessment , 2016 .